Awareness of obesity as a global health crisis continues to grow and the commercial landscape for obesity treatments is undergoing unprecedented transformation. Findings from Ipsos' Global Perceptions of Obesity Study - publicly released on World Obesity Day 2026 - provides important societal insights and understanding of the human experience of living with obesity, alongside comparative analysis of those not living with the condition. But critical commercial intelligence remains exclusive - this includes complete US market data and granular demographic breakdowns essential for strategic decision-making.
Through a comprehensive survey of 15,500 adults across 15 countries, including 1,000 US respondents, Ipsos delivers actionable commercial insights that go beyond publicly available findings by analysing data across several demographics of your choice, e.g., people using GLP-1s, people overweight, high vs low income, ethnicity.
Purchase of the full series provides complete commercial intelligence across all markets and demographics, while individual modules allow targeted focus on your highest-priority strategic questions. The US report stands alone as a comprehensive market analysis with no data released publicly — a crucial tool for North American strategy.
Sample excerpt from report